Swine Flu Vaccine Safety Questions: CANADA: GlaxoSmithKline recalls batch of H1N1 Vaccine after higher than usual reports of anaphylaxis

Friday, November 20, 2009

CANADA: GlaxoSmithKline recalls batch of H1N1 Vaccine after higher than usual reports of anaphylaxis

CANADA: More than 100,000 doses of the H1N1 vaccine are being withdrawn across the country, after Manitoba health officials announced Thursday they'd noticed a higher-than-usual number of allergic reactions from one batch.
Vaccine manufacturer GlaxoSmithKline has asked several provinces to set aside the 170,000 doses from the questionable batch.
READ MORE HERE:
http://www.ctv.ca/servlet/ArticleNews/story/CTVNews/20091119/Flu_Reaction_091119/20091120?hub=Health

Terms You Should Know

Adjuvant- In immunology, an adjuvant is an agent that may stimulate the immune system and increase the response to a vaccine, without having any specific antigenic effect in itself. (definition from wikipedia)

Two Adjuvant that may be used in the Swine Flu Vaccines that are cause for concern: MF59 and ASO3

“……Vaccines containing MF59 and ASO3 have not had Emergency Use Authorizations issued for them--yet. However, the government has purchased $698 million dollars' worth of these adjuvants in recent weeks.

http://www.hhs.gov/news/press/2009pres/07/20090713b.html https://

and WHO officials have indicated the likelihood of their use, which is the only way to achieve adequate amounts of vaccine for the US and world population in the fall.…..These vaccines have never been demonstrated to be safe in children, pregnant women or young adults. They have not undergone comprehensive testing; for example, MF59 has not and will not be tested for carcinogenicity by the manufacturer.
(See page 391)
http://www.fda.gov/downloads/BiologicsBloodVaccines/NewsEvents/WorkshopsMeetingsConferences/ucm095708.pdf